Schizophrenia is a devastating mental illness with a strong genetic component that is the
subject of extensive research. Despite the high heritability, it is well recognized that non …

Background: On the current psychopharmacological panorama, the variety of substances
able to provoke an episode of acute psychosis is rapidly increasing. Such psychotic …

Background Cannabis use is associated with increased risk of later psychotic disorder but
whether it affects incidence of the disorder remains unclear. We aimed to identify patterns of …

Objective: This review discusses the relationship between cannabis use and psychotic,
bipolar, depressive, and anxiety disorders, as well as suicide. It summarizes epidemiological …

Cannabidiol (CBD), as a major phytocannabinoid of Cannabis sativa, has emerged as a
promising natural compound in the treatment of diseases. Its diverse pharmacological …

Background: The landscape of attitudes, legal status and patterns of use of cannabis is
rapidly changing in the United States and elsewhere. Therefore, the primary aim of this …

Aims To summarize and evaluate our knowledge of the relationship between heavy
cannabis use, cannabis use disorder (CUD) and the brain. Methods Narrative review of …

Simple Summary This review was aimed at exploring the potentiality of drugging the
endocannabinoid system as a therapeutic option for Alzheimer's disease (AD). Recent …

Legalization and commercial sale of non-medical cannabis has led to increasing diversity
and potency of cannabis products. Some of the American states that were the first to legalize …

Cannabis is the most used drug of abuse worldwide. It is well established that the most
abundant phytocannabinoids in this plant are Δ9-tetrahydrocannabinol (THC) and …